Cleared Traditional

K881933 - KALLESTAD QUANTAFLUOR ANTITHYROID ANTIBODY TEST

K881933 is an FDA 510(k) clearance for KALLESTAD QUANTAFLUOR ANTITHYROID ANTIB..., manufactured by Kallestad Diag, A Div. of Erbamont, Inc.. The device is a Class 2 Immunology device with product code JZO cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K881933 · Kallestad Diag, A Div. of Erbamont, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1988
Decision
27d
Days
Class 2
Risk

K881933 is an FDA 510(k) clearance for the KALLESTAD QUANTAFLUOR ANTITHYROID ANTIBODY TEST. Classified as System, Test, Thyroid Autoantibody (product code JZO), Class II - Special Controls.

Submitted by Kallestad Diag, A Div. of Erbamont, Inc. (Chaska, US). The FDA issued a Cleared decision on June 6, 1988 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5870 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Kallestad Diag, A Div. of Erbamont, Inc. devices

FDA 510(k) Submission Details - K881933

510(k) Number K881933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 1988
Decision Date June 06, 1988
Days to Decision 27 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 105d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JZO Device Classification - Class 2, Special Controls

Product Code JZO System, Test, Thyroid Autoantibody
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - JZO System, Test, Thyroid Autoantibody

All 71
Devices cleared under the same product code (JZO) and FDA review panel - the closest regulatory comparables to K881933.
SYNELISA TGAB/TMAB
K915135 · Elias U.S.A., Inc. · Apr 1992
IMMUNOWELL THYROGLOBULIN TEST
K905485 · General Biometrics, Inc. · Jan 1991
NOVA LITE TM THYROID
K904224 · Inova Diagnostics, Inc. · Oct 1990
SERA-TEK MICROSOMAL ANTIBODY TEST
K865053 · Miles Laboratories, Inc. · Feb 1987
CORDIA TG
K821489 · Cordis Corp. · Jun 1982
AGGLUTINOTEST-THYROGLOBULIN
K791458 · Volu Sol Medical Industries · Dec 1979